Adozelesin is an experimental antitumor drug of the duocarmycin class.

[1] It binds to and alkylates DNA, resulting in a reduction of both cellular and simian virus 40 (SV40) DNA replication which ultimately reduces the rate of cancer growth.

[2] This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.